AZIYO BIOLOGICS INC-CLASS A (AZYO) Stock Price, Forecast & Analysis
NASDAQ:AZYO • US05479K1060
AZYO Key Statistics, Chart & Performance
The current stock price of AZYO is 1.49 USD. In the past month the price decreased by -1.97%. In the past year, price decreased by -79.62%.
AZYO Technical Analysis
AZYO Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to AZYO. AZYO has a bad profitability rating. Also its financial health evaluation is rather negative.
AZYO Financial Highlights
Over the last trailing twelve months AZYO reported a non-GAAP Earnings per Share(EPS) of -2.25. The EPS increased by 22.95% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | N/A | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
AZYO Forecast & Estimates
7 analysts have analysed AZYO and the average price target is 8.16 USD. This implies a price increase of 447.65% is expected in the next year compared to the current price of 1.49.
For the next year, analysts expect an EPS growth of 9.47% and a revenue growth -12.95% for AZYO
AZYO Ownership
AZYO Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 15.67 | 390.397B | ||
| AMGN | AMGEN INC | 16.25 | 197.396B | ||
| GILD | GILEAD SCIENCES INC | 17.02 | 193.298B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 22.81 | 117.026B | ||
| REGN | REGENERON PHARMACEUTICALS | 16.87 | 81.87B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | 46.05 | 42.576B | ||
| INSM | INSMED INC | N/A | 31.656B | ||
| NTRA | NATERA INC | N/A | 29.322B | ||
| BIIB | BIOGEN INC | 12.85 | 28.06B | ||
| UTHR | UNITED THERAPEUTICS CORP | 16.16 | 20.49B |
Related stock screener links
View all stocks in the Biotechnology Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About AZYO
Company Profile
Aziyo Biologics, Inc. operates as a biotechnology company. The company is headquartered in Silver Spring, Maryland and currently employs 151 full-time employees. The company went IPO on 2020-10-08. The firm has developed a portfolio of regenerative products using both human and porcine tissue that are designed to be as close to natural biological material. The firm operates in four segments: Device Protection, Women's Health, Orthobiologics, and Cardiovascular. Its product portfolio includes CanGaroo, SimpliDerm, ViBone, OsteGro V, Fiber VBM, ProxiCor, Tyke, and VasCure. These products are primarily sold to healthcare providers or commercial partners. In device protection, it sells biological envelopes that form a natural, systemically vascularized pocket for holding implanted electronic devices. In cardiovascular, the Company sells its specialized porcine small intestine submucosa (SIS ECM) for use as an intracardiac and vascular patch. The company also sells human tissue products under contract manufacturing and other arrangements with corporate customers.
Company Info
AZIYO BIOLOGICS INC-CLASS A
12510 Prosperity Drive, Suite 370
Silver Spring MARYLAND 20904 US
CEO: Ronald Lloyd
Employees: 151
Phone: 12402471143.0
AZIYO BIOLOGICS INC-CLASS A / AZYO FAQ
What does AZYO do?
Aziyo Biologics, Inc. operates as a biotechnology company. The company is headquartered in Silver Spring, Maryland and currently employs 151 full-time employees. The company went IPO on 2020-10-08. The firm has developed a portfolio of regenerative products using both human and porcine tissue that are designed to be as close to natural biological material. The firm operates in four segments: Device Protection, Women's Health, Orthobiologics, and Cardiovascular. Its product portfolio includes CanGaroo, SimpliDerm, ViBone, OsteGro V, Fiber VBM, ProxiCor, Tyke, and VasCure. These products are primarily sold to healthcare providers or commercial partners. In device protection, it sells biological envelopes that form a natural, systemically vascularized pocket for holding implanted electronic devices. In cardiovascular, the Company sells its specialized porcine small intestine submucosa (SIS ECM) for use as an intracardiac and vascular patch. The company also sells human tissue products under contract manufacturing and other arrangements with corporate customers.
What is the current price of AZYO stock?
The current stock price of AZYO is 1.49 USD. The price increased by 2.05% in the last trading session.
Does AZIYO BIOLOGICS INC-CLASS A pay dividends?
AZYO does not pay a dividend.
What is the ChartMill technical and fundamental rating of AZYO stock?
AZYO has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
What do analysts say about AZIYO BIOLOGICS INC-CLASS A (AZYO) stock?
7 analysts have analysed AZYO and the average price target is 8.16 USD. This implies a price increase of 447.65% is expected in the next year compared to the current price of 1.49.
What is AZIYO BIOLOGICS INC-CLASS A worth?
AZIYO BIOLOGICS INC-CLASS A (AZYO) has a market capitalization of 24.21M USD. This makes AZYO a Nano Cap stock.